APA (7th ed.) Citation

Ohyashiki JH, Ohtsuki K, Mizoguchi I, Yoshimoto T, Katagiri S, Umezu T, & Ohyashiki K. (2014). Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: A possible biomarker to discontinue imatinib safely. Dove Medical Press.

Chicago Style (17th ed.) Citation

Ohyashiki JH, Ohtsuki K, Mizoguchi I, Yoshimoto T, Katagiri S, Umezu T, and Ohyashiki K. Downregulated MicroRNA-148b in Circulating PBMCs in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease: A Possible Biomarker to Discontinue Imatinib Safely. Dove Medical Press, 2014.

MLA (9th ed.) Citation

Ohyashiki JH, et al. Downregulated MicroRNA-148b in Circulating PBMCs in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease: A Possible Biomarker to Discontinue Imatinib Safely. Dove Medical Press, 2014.